Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMatthew Allemang
About this trial
This study will assess changes in glycemic control in 40 patients with diabetes who undergo per-oral pyloromyotomy (POP) for medically refractory gastroparesis.
Eligibility criteria
Qualifiers
Patients 18 years of age and older
Patients with gastroparesis with an average HbA1c> 7.5% over the past 3 months
Patient that have a diagnosis of gastroparesis established by documented delayed gastric emptying by either a wireless motility capsule study or a nuclear gastric emptying study, with no evidence of gastric obstruction.
Patients are able to complete all study requirements
Disqualifiers
Patients <18 years of age
Patients with gastroparesis with an average HbA1c< 7.5% over the past 3 months
Patients unable or refuse to complete the study requirements
Patients who are unable or refuse to wear a CGM sensor
Trial design
Treatments tested in this trial
- Pyloromyotomy
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Matthew Allemang
Lead sponsor
The Cleveland Clinic
Sponsor institution
Society of American Gastrointestinal and Endoscopic Surgeons
Collaborator
Source ClinicalTrials.gov